Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons
Abstract
a-synuclein accumulation into dopaminergic neurons is a pathological hallmark of Parkinson’s
disease. We previously demonstrated that fatty acid-binding protein 3 (FABP3) is critical for
a-synuclein uptake and propagation to accumulate in dopaminergic neurons. FABP3 is abundant in
dopaminergic neurons and interacts with dopamine D2 receptors, specifically the long type (D2L).
Here, we investigated the importance of dopamine D2L receptors in the uptake of a-synuclein
monomers and their fibrils. We employed mesencephalic neurons derived from dopamine D2L
-/-, dopamine D2 receptor null (D2 null), FABP3-/-, and wild type C57BL6 mice, and analyzed the
uptake ability of fluorescence-conjugated a-synuclein monomers and fibrils. We found that D2L
receptors are co-localized with FABP3. Immunocytochemistry revealed that TH+ D2L/- or D2 null
neurons do not take up a-synuclein monomers. The deletion of a-synuclein C-terminus completely
abolished the uptake to dopamine neurons. Likewise, dynasore, a dynamin inhibitor, and caveolin-1
knockdown also abolished the uptake. D2L and FABP3 were also critical for a-synuclein fibrils
uptake. D2L and accumulated a-synuclein fibrils were well co-localized. These data indicate that
dopamine D2L with a caveola structure coupled with FABP3 is critical for a-synuclein uptake by
dopaminergic neurons, suggesting a novel pathogenic mechanism of synucleinopathies, including
Parkinson’s disease.
Origin : Publisher files allowed on an open archive